Feedback / Questions
Nemluvio (nemolizumab-ilto) - Galderma
https://www.businesswire.com/news/home/20250423395846/en/Galderma-Delivers-Record-First-Quarter-Net-Sales-of-1.129-Billion-USD-Including-Strong-Performance-From-Two-Launches-With-Blockbuster-Potential-and-Confirms-Full-Year-Guidance
Apr 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next